Article info

Download PDFPDF

36 Triple Therapy Anticoagulation following Percutaneous Coronary Intervention (PCI) with Novel Oral Anticoagulants (NOAC) is Safe and has no Adverse Effects on Bleeding Post Procedure when Compared to Triple Therapy with Vitamin K Antagonist (VKA)
Free

Authors

Citation

Amin R, McWilliams N, Lee D, et al
36 Triple Therapy Anticoagulation following Percutaneous Coronary Intervention (PCI) with Novel Oral Anticoagulants (NOAC) is Safe and has no Adverse Effects on Bleeding Post Procedure when Compared to Triple Therapy with Vitamin K Antagonist (VKA)

Publication history

  • First published June 3, 2016.
Online issue publication 
June 03, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.